IL137722A0 - Pharmaceutical compositions for ulcer - Google Patents

Pharmaceutical compositions for ulcer

Info

Publication number
IL137722A0
IL137722A0 IL13772299A IL13772299A IL137722A0 IL 137722 A0 IL137722 A0 IL 137722A0 IL 13772299 A IL13772299 A IL 13772299A IL 13772299 A IL13772299 A IL 13772299A IL 137722 A0 IL137722 A0 IL 137722A0
Authority
IL
Israel
Prior art keywords
ulcer
pharmaceutical compositions
component
compounds containing
components
Prior art date
Application number
IL13772299A
Other languages
English (en)
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of IL137722A0 publication Critical patent/IL137722A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13772299A 1998-03-05 1999-02-25 Pharmaceutical compositions for ulcer IL137722A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI000443A IT1298338B1 (it) 1998-03-05 1998-03-05 Composizioni farmaceutiche per l'ulcera
PCT/EP1999/001225 WO1999044595A2 (fr) 1998-03-05 1999-02-25 Compositions pharmaceutiques anti-ulcereuses

Publications (1)

Publication Number Publication Date
IL137722A0 true IL137722A0 (en) 2001-10-31

Family

ID=11379187

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13772299A IL137722A0 (en) 1998-03-05 1999-02-25 Pharmaceutical compositions for ulcer

Country Status (17)

Country Link
US (2) US6436975B1 (fr)
EP (1) EP1083887B1 (fr)
JP (1) JP2002505276A (fr)
KR (1) KR100579810B1 (fr)
CN (1) CN1210027C (fr)
AT (1) ATE305791T1 (fr)
AU (1) AU757155B2 (fr)
BR (1) BR9908427A (fr)
CA (1) CA2322865C (fr)
DE (1) DE69927584T2 (fr)
DK (1) DK1083887T3 (fr)
ES (1) ES2251180T3 (fr)
HU (1) HUP0203648A3 (fr)
IL (1) IL137722A0 (fr)
IT (1) IT1298338B1 (fr)
RU (1) RU2227030C2 (fr)
WO (1) WO1999044595A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552047B2 (en) 1998-11-17 2003-04-22 Nitromed, Inc. H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
SE0002476D0 (sv) * 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
CA2432642A1 (fr) 2000-12-21 2002-08-08 Subhash P. Khanapure Composes aryle substitues en tant que nouveaux inhibiteurs selectifs de la cyclo-oxygenase-2, compositions et methodes d'utilisation
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
CA2493156A1 (fr) 2002-07-29 2004-02-05 Nitromed, Inc. Inhibiteurs selectifs de la cyclo-oxygenase-2, compositions et procedes d'utilisation
AU2003254282A1 (en) * 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
EP2669269B1 (fr) 2005-05-27 2019-05-22 The University of North Carolina At Chapel Hill Particules libérant de l'oxyde nitrique pour thérapie à base d'oxyde nitrique et applications biomédicales
US20100098733A1 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
WO2011022652A1 (fr) 2009-08-21 2011-02-24 Novan, Inc. Gels topiques
EP2467173B8 (fr) 2009-08-21 2019-06-19 Novan, Inc. Pansements, procédés d'utilisation de ceux-ci et procédés de formation de ceux-ci
WO2011047013A1 (fr) * 2009-10-13 2011-04-21 Novan, Inc. Revêtements libérant de l'oxyde nitrique
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (fr) 2011-02-28 2012-09-07 Novan, Inc. Particules de silice modifiées par des groupements s-nitrosothiols libérant de l'oxyde nitrique et procédés de fabrication associés
RU2539630C1 (ru) * 2013-07-09 2015-01-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ профилактики ишемии сетчатки в эксперименте

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3775796B2 (ja) * 1993-10-06 2006-05-17 ニコックス エス エイ 抗炎症活性及び/又は鎮痛活性を有する硝酸エステル類及びそれらの製造方法
IT1282686B1 (it) * 1996-02-26 1998-03-31 Nicox Sa Composti in grado di ridurre la tossicita' da farmaci

Also Published As

Publication number Publication date
ES2251180T3 (es) 2006-04-16
WO1999044595A2 (fr) 1999-09-10
AU757155B2 (en) 2003-02-06
EP1083887B1 (fr) 2005-10-05
EP1083887A2 (fr) 2001-03-21
HUP0203648A2 (hu) 2003-02-28
CN1291896A (zh) 2001-04-18
DK1083887T3 (da) 2006-01-16
DE69927584D1 (de) 2006-02-16
US20030027844A1 (en) 2003-02-06
KR100579810B1 (ko) 2006-05-12
US6436975B1 (en) 2002-08-20
WO1999044595A3 (fr) 1999-11-25
ITMI980443A1 (it) 1999-09-05
KR20010034547A (ko) 2001-04-25
BR9908427A (pt) 2000-10-31
DE69927584T2 (de) 2006-07-13
IT1298338B1 (it) 1999-12-20
RU2227030C2 (ru) 2004-04-20
AU2726399A (en) 1999-09-20
JP2002505276A (ja) 2002-02-19
CA2322865C (fr) 2009-12-08
ATE305791T1 (de) 2005-10-15
CN1210027C (zh) 2005-07-13
CA2322865A1 (fr) 1999-09-10
HUP0203648A3 (en) 2006-07-28

Similar Documents

Publication Publication Date Title
WO1999044595A3 (fr) Compositions pharmaceutiques anti-ulcereuses
TW272195B (fr)
YU28199A (sh) Novi oblik jedinjenja
AU2092497A (en) Nitric oxide donors capable of reducing toxicity from drugs
FR2710063B1 (fr) 3-Aryl-benzofurannones, utilisées en tant que stabilisants, compositions les contenant, et leur utilisation.
NO930863L (no) Randomiserte kopolymermaterialer av propylen med et alfa-olefin som komonomer, og en fremgangsmaate for fremstilling av slike
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EE03177B1 (et) Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
ITFI930083A0 (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL108648A0 (en) Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing them
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
TR26619A (tr) YENI BILESIKLER,BUNLARIN HAZIRLANMALARINA YÖNELIK ISLEMLER,BUNLARI ICEREN BILESIMLER VE BUNLARIN ZARARLI OT ÖLDüRüCüSü(HERBISIDAL) OLARAK KULLANI- MI.
EP0643090A3 (fr) Compositions contenant des composés organo-silicium pour le traitement de matériaux fibreux.
CA2200126A1 (fr) Traitement et prophylaxie de la pancreatite
ZA911804B (en) 1-azabicyclic compounds,processes and pharmaceutical compositions containing them
FR2708609B1 (fr) Dérivés de méthylguanidine, leurs procédés de préparation ainsi que les compositions en contenant.
AU5116590A (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
ZA849972B (en) New benzimidazoles,the preparation thereof and pharmaceutical compositions containing these compounds
IL91675A0 (en) Cyclic compounds,pharmaceutical compositions containing the same and processes for the preparation thereof
EP0049354A3 (fr) Composition pour utilisation thérapeutique anti-virus et articles et emballages contenant ladite composition
AU8452891A (en) Calcium uptake inhibitors
IL109866A0 (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it
IT1207996B (it) Composti contenenti ferro biodisponibile, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees